2,898 Shares in Axon Enterprise, Inc $AXON Acquired by J. Safra Sarasin Holding AG

Key Points

• J. Safra Sarasin Holding AG acquired 2,898 shares of Axon Enterprise, Inc, worth approximately $2.4 million, during the second quarter.
• Axon reported a 32.6% year-over-year increase in revenue, with earnings per share of $2.12, surpassing estimates by $0.58.
• The stock is highly rated with an average target price of $841.64, and 14 analysts have classified it as a "Buy".

J. Safra Sarasin Holding AG purchased a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,898 shares of the biotechnology company's stock, valued at approximately $2,399,000.

Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in Axon Enterprise by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock worth $4,540,005,000 after purchasing an additional 185,571 shares during the period. Alliancebernstein L.P. boosted its position in Axon Enterprise by 15.9% during the first quarter. Alliancebernstein L.P. now owns 1,284,935 shares of the biotechnology company's stock valued at $675,812,000 after buying an additional 175,890 shares during the period. Westfield Capital Management Co. LP grew its stake in shares of Axon Enterprise by 29.8% during the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock valued at $487,977,000 after buying an additional 212,931 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Axon Enterprise by 1.2% in the first quarter. Northern Trust Corp now owns 725,720 shares of the biotechnology company's stock worth $381,692,000 after buying an additional 8,794 shares during the period. Finally, Jennison Associates LLC lifted its stake in shares of Axon Enterprise by 23,203.7% in the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock valued at $322,961,000 after acquiring an additional 611,418 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Price Performance

AXON opened at $715.51 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a 52-week low of $413.68 and a 52-week high of $885.91. The stock has a market capitalization of $56.17 billion, a PE ratio of 176.67, a price-to-earnings-growth ratio of 27.98 and a beta of 1.41. The stock's 50 day moving average price is $757.79 and its 200-day moving average price is $707.36.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. During the same period in the previous year, the firm earned $1.20 earnings per share. The business's revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insider Activity at Axon Enterprise

In related news, CFO Brittany Bagley sold 5,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, September 29th. The stock was sold at an average price of $713.88, for a total transaction of $3,569,400.00. Following the sale, the chief financial officer directly owned 93,592 shares in the company, valued at $66,813,456.96. The trade was a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Jennifer H. Mak sold 77 shares of Axon Enterprise stock in a transaction that occurred on Monday, September 15th. The shares were sold at an average price of $760.00, for a total value of $58,520.00. Following the sale, the chief accounting officer owned 15,003 shares in the company, valued at $11,402,280. This represents a 0.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 49,932 shares of company stock valued at $37,978,216 over the last ninety days. Insiders own 4.40% of the company's stock.

Analyst Ratings Changes

AXON has been the topic of a number of analyst reports. Piper Sandler initiated coverage on Axon Enterprise in a research note on Tuesday, September 23rd. They issued an "overweight" rating and a $893.00 price target on the stock. Craig Hallum raised Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price target on the stock in a research note on Tuesday, August 5th. JMP Securities reaffirmed a "market outperform" rating and issued a $825.00 price target on shares of Axon Enterprise in a research note on Monday, September 29th. Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the stock an "overweight" rating in a research note on Friday, July 11th. Finally, JPMorgan Chase & Co. lifted their price target on Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a research note on Thursday, July 17th. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.